Is a pacemaker recommended for a patient with Hypertrophic Obstructive Cardiomyopathy (HOCM), 5% non-scheming scar burden, and Mobitz I bradycardia, who has experienced multiple falls?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pacemaker Recommendation for HOCM Patient with Mobitz I Bradycardia and Multiple Falls

A permanent pacemaker is recommended for this 61-year-old man with HOCM, 5% non-ischemic scar burden, Mobitz I bradycardia, and multiple falls, as he meets criteria for bradycardia pacing and may additionally benefit from reduction in LVOT obstruction. 1

Primary Indication: Bradycardia with Falls

  • Mobitz I bradycardia in a patient with multiple falls represents a strong indication for permanent pacemaker implantation, as bradycardia can contribute to falls and syncope 1
  • The presence of multiple falls in this patient suggests a potential causal relationship between the bradycardia and his symptoms, which supports pacemaker implantation 1
  • Studies have shown that pacing can reduce syncope recurrence and fall events in patients with bradycardia-related symptoms 1

Additional Benefit in HOCM

  • In patients with HOCM who require pacing for bradycardia indications, there is an additional potential benefit of reducing left ventricular outflow tract obstruction 1
  • While pacing is not a first-line therapy for HOCM symptom management, it is reasonable to consider dual-chamber pacing for patients with HOCM who have had a device implanted for non-HOCM indications 1
  • The American College of Cardiology/American Heart Association guidelines specifically state that DDD pacing can be useful for patients with medically refractory, symptomatic HOCM with significant resting or provoked left ventricular outflow obstruction 1

Pacing Mode Considerations

  • A dual-chamber (DDD) pacemaker is preferred over a single-chamber device in this patient with HOCM 1
  • DDD pacing with a short AV delay can reduce LVOT gradient by altering septal activation pattern and increasing end-systolic volume 1
  • Right ventricular apical pacing is the recommended location to achieve the greatest reduction in LVOT gradient 1

Cautions and Considerations

  • Bradycardia can actually worsen LVOT obstruction in HOCM, making this patient's Mobitz I bradycardia potentially more symptomatic than in patients without HOCM 2
  • The patient's 5% non-ischemic scar burden should be considered when evaluating overall risk, but does not contraindicate pacemaker implantation 1
  • Pacemaker implantation carries a small risk of complications including pneumothorax (1.5-2%), lead dislodgement (1-4%), and device malfunction (0.1-0.2%) 1
  • Shared decision-making should be employed, discussing the benefits of symptom improvement and fall prevention against the risks of the procedure 1

Programming Recommendations

  • Program a relatively short AV delay (typically 100-150 ms) to ensure ventricular pre-excitation and maximize reduction in LVOT gradient 1, 3
  • Set an upper rate limit higher than the fastest sinus rate achievable during exercise to prevent functional atrial undersensing 1
  • Consider rate-responsive features to maintain appropriate heart rate during activity, as heart rate increase during exercise is important for maintaining cardiac output 4

Follow-up Recommendations

  • Regular device checks to ensure proper functioning and optimization of AV delay 3
  • Continued monitoring for symptoms of HOCM and bradycardia 1
  • Assessment of LVOT gradient reduction after pacemaker implantation to evaluate effectiveness 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2018

Research

Pacemaker hemodynamics: clinical implications.

Progress in cardiovascular diseases, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.